Closing Bell: Nervgen Pharma Corp down on Friday (NGEN)

In today's trading, Nervgen Pharma Corp shares opened at $2.71 and closed at $2.69. Intraday prices ranged from $2.51 to $2.85.

The price reduced -1.82 percent from the previous day's close of $2.74.

Today across North America, the TSX Composite closed -0.30% at 21875.79, the S&P 500 closed -0.41% at 5460.48, the Dow Jones Industrial Average closed -0.12% at 39118.86 and the Nasdaq Composite closed -0.71% at 17732.60.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 129,909 shares was traded during the session, with total trades of 168. On average, Nervgen Pharma Corp has traded 125,035 shares over 5 days and 90,626 year-to-date.

Trading across the entire TSX-V saw 1,678 price advancers against 3,535 declines and 105 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 52 weeks, Nervgen Pharma Corp's shares have soared 60.12 percent, while in 2024, they have dipped -0.37%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $188.10 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..